Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

15.83
-0.2700-1.68%
Post-market: 15.43-0.4000-2.53%19:30 EDT
Volume:921.17K
Turnover:14.68M
Market Cap:874.52M
PE:-5.74
High:16.91
Open:16.32
Low:15.33
Close:16.10
52wk High:16.93
52wk Low:5.97
Shares:55.24M
Float Shares:42.02M
Volume Ratio:0.45
T/O Rate:2.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7580
EPS(LYR):-2.4200
ROE:-43.25%
ROA:-25.09%
PB:2.15
PE(LYR):-6.54

Loading ...

Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2026

Major Issues Report

Form 8-K - Current report
Aug 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2026

Major Issues Report

Form 8-K - Current report
Jun 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 12, 2026

Correspondence

Form CORRESP - Correspondence